Drug Type Small molecule drug |
Synonyms AOB-01, AOB01 |
Target |
Action antagonists |
Mechanism ARF1 antagonists(ADP ribosylation factor 1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | IND Approval | China | 15 Mar 2026 |





